Abstract | OBJECTIVE: METHOD: Neonatal rat cardiomyocytes was treated with or without 10(-7) mol/L rPTH1-34 in the absence or presence 2 x 10(-5) mol/L PD98059, a MEK1 inhibitor. Cellular diameter was measured by Motic Images Advanced 3.0 software and the synthetic rate of protein in cardiac myocytes was detected by 3H-leucine incorporation, mRNA expression of atrial natriuretic peptide ( ANP) was measured by RT-PCR and protein expression of ERK1/2 and p-ERK1/2 was measured by Western blot. RESULTS: rPTH1-34 (10(-7) mol/L) significantly increase cellular diameter (+13.6 microm), 3H-leucine incorporation (+898 cpm/well), ANP mRNA expression (+73.9%), and p-ERK1/2 protein expression (+15%) compared to control cells (all P < 0.05) and these effects could be significantly attenuated by PD98059: cellular diameter (-7.1 microm), 3H-leucin e incorporation (-644 cpm/well), ANP mRNA expression (-52.2%), and protein expression of p-ERK1/2 (-18%) (all P < 0.05 vs. PTH group). PD98059 did not affect control cells without PTH treatment (all P > 0.05). CONCLUSIONS:
|
Authors | Xiao-gang Liu, Hui-xia An, Su-yan Liu, Ye-ping Ren, Wei-bing Zhang |
Journal | Zhonghua xin xue guan bing za zhi
(Zhonghua Xin Xue Guan Bing Za Zhi)
Vol. 36
Issue 5
Pg. 439-43
(May 2008)
ISSN: 0253-3758 [Print] China |
PMID | 19100042
(Publication Type: Journal Article)
|
Chemical References |
- Flavonoids
- Parathyroid Hormone
- Atrial Natriuretic Factor
- MAP Kinase Kinase 1
- MAP Kinase Kinase 2
- 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
|
Topics |
- Animals
- Atrial Natriuretic Factor
(metabolism)
- Cardiomegaly
(chemically induced, metabolism)
- Cells, Cultured
- Flavonoids
(pharmacology)
- Gene Expression Regulation
- MAP Kinase Kinase 1
(metabolism)
- MAP Kinase Kinase 2
(metabolism)
- MAP Kinase Signaling System
- Myocytes, Cardiac
(metabolism)
- Parathyroid Hormone
(adverse effects)
- Rats
- Rats, Wistar
|